semaglutide stimulant may reduce opioid overdoses, a new study suggests FDA Warns on Certain Forms

New drugs that affect synaptic plasticity, social learning or neuroinflammation must be combined with psychological interventions to achieve complementary synergies that ultimately have a major impact on the long-term outcomes of individuals with autism

Tirzepatide (Mounjaro) : A dual GIP/GLP-1 receptor agonist injection authorised by the MHRA

They're effective at inducing sleep but often suppress beneficial sleep stages and can cause dependence

Administered under strict medical supervision, Aclonist 250 ensures precise dosing and minimizes the risk of adverse effects

10.1016/S0149-2918(00)88479-9 Clin Ther

Research points to clear, practical strategies that can protect lean mass during GLP-1 therapy